Navidea Biopharmaceuticals, Inc (NAVB) |
|---|
| $0.26 52 Week Low | $0.49 2017-04-28 14:34:28 MDT | $1.51 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| NYSE Stock Exchange | United States Country |
| Market Cap: | $71,420,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 5 | Analysts say: Strong Sell. (1=Strong Buy, 5=Strong Sell) |
| Beta: | -0.97 | Unusual negative beta. Good for diversity? Stock may go up when market goes down, and down when market goes up. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -12.50% | % Above 200 DayMA: -24.62% |
NAVB Performance 52 Weeks: -66.67% | S&P 500 Performance 52 Weeks: 13.50% |
Downtrend is still intact: NAVB is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | NAVB underperforming S&P 500 by -80.17% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: -76.43 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 1.14% | 17.28% | Held by fewer than average Insiders. |
| % Held By Institutions | 35.00% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | 8.37% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | -65.13% | -00.18% | Profit Margin is less than average. |
| Operating Margin % | -10.12% | -05.28% | Operating Margin less than average percent. Stock can do better than this? |
| Return on Equity % | N/A | -08.79% | Unknown. |
| Return on Assets % | -10.13% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $998,636.36 | $883,096.70 | More than average Revenue Per Employee. This stock (or industry) could be very efficient. |
| Price to Cash | 49.00 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS: | CONS:
|